EUVIMEDOpdag EUVIMED
Crossref

Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4 – LPS ‐Mediated Migration in Triple‐Negative Breast Cancer Cells

S K Batin Rahaman, Satyajit Halder, Kuldeep K Roy, Pallab K Halder, Utsab Debnath, Kuladip Jana

Chemical Biology & Drug Design · 2025-03 · 105 (3)

DOI: 10.1111/cbdd.70089 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2025-03-24. Written by S K Batin Rahaman and 5 co-authors. Institution: Department of Pharmaceutical Science, School of Health Sciences and Technology, UPES, Dehradun, India. Major MEDLINE topics: Toll-Like Receptor 4, Cell Movement, Lipopolysaccharides, Cell Proliferation. Cited 4 times so far (Crossref); 25 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The Toll‐like receptor 4 (TLR4) signaling pathway plays a leading role in triggering proinflammatory responses by targeting lipopolysaccharide (LPS) molecules from different bacteria. Meanwhile, it is also expressed at higher levels in breast cancer cells than in normal breast tissue. After LPS binding, it initiates downstream signaling pathways that promote inflammation and cell apoptosis. Thus, targeting TLR4–LPS presents a promising dual therapeutic strategy for breast cancer treatment by not only inhibiting tumor growth but also reducing inflammation within the tumor microenvironment. To achieve this, the discovery of a new antiinflammatory agent is needed to reduce LPS‐mediated cancer cell proliferation and migration. In this study, a series of 4‐aminoquinoline–thiazolidinone hybrid analogs (4a‐m) have been synthesized to explore their antiinflammatory as well as anticancer activity to find a new lead. Among them, 4e revealed the most promising antiinflammatory (IC50 = 2.38 ± 0.77 μM) as well as anticancer activity (IC50 = 3.26 ± 1.06 μM) in RAW 267.7 cell line and triple‐negative breast cancer (TNBC) cell line, respectively. Further structure–activity relationship study followed by MD simulation analysis was carried out to identify probable binding residues of TLR4 which may play a significant role in developing antiinflammatory activity for promoting cell apoptosis in cancer cells.

Subjects

MeSH terms (MEDLINE)

Toll-Like Receptor 4Cell MovementLipopolysaccharidesCell ProliferationAntineoplastic AgentsTriple Negative Breast NeoplasmsThiazolidinesAminoquinolinesMolecular Docking SimulationHumansCell Line, TumorMiceFemaleAnimalsStructure-Activity RelationshipRAW 264.7 CellsAnti-Inflammatory AgentsApoptosis

Author keywords

4‐amino quinoline–thiazolidinoneMD simulation analysisToll‐like receptor 4 (TLR4)anticancer activityantiinflammatory activitylipopolysaccharide (LPS)structure–activity relationship (SAR) study

Substances

Toll-Like Receptor 4LipopolysaccharidesAntineoplastic AgentsThiazolidinesAminoquinolines4-aminoquinolineTLR4 protein, humanAnti-Inflammatory Agents

Authors and institutions

  • Department of Pharmaceutical Science, School of Health Sciences and Technology, UPES, Dehradun, India.
  • Department of Molecular Medicine, Bose Institute, Kolkata, India.
  • School of Natural Product Studies, Jadavpur University, Kolkata, India.

Cite

APA

Batin Rahaman, S. K., Halder, S., Roy, K. K., Halder, P. K., Debnath, U., & Jana, K. (2025). Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4 – LPS ‐Mediated Migration in Triple‐Negative Breast Cancer Cells. Chemical Biology & Drug Design, 105(3). https://doi.org/10.1111/cbdd.70089

Vancouver

Batin Rahaman SK, Halder S, Roy KK, Halder PK, Debnath U, Jana K. Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4 – LPS ‐Mediated Migration in Triple‐Negative Breast Cancer Cells. Chemical Biology & Drug Design. 2025;105(3). doi:10.1111/cbdd.70089

BibTeX
@article{BatinRahaman2025,
  author = {Batin Rahaman, S K and Halder, Satyajit and Roy, Kuldeep K and Halder, Pallab K and Debnath, Utsab and Jana, Kuladip},
  title = {Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4 – LPS ‐Mediated Migration in Triple‐Negative Breast Cancer Cells},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  volume = {105},
  number = {3},
  doi = {10.1111/cbdd.70089}
}
Start for free →